🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/01/2024 | 117,65 | 118,62 | 116,62 | 118,54 | +0,35% | 1,70% | 10.524.700 |
| 17/01/2024 | 119,18 | 119,40 | 117,61 | 118,13 | -0,30% | 1,50% | 5.591.400 |
| 16/01/2024 | 118,49 | 119,34 | 117,94 | 118,49 | -0,12% | 1,18% | 6.832.300 |
| 12/01/2024 | 118,07 | 118,67 | 117,65 | 118,63 | +0,17% | 0,86% | 6.823.300 |
| 11/01/2024 | 118,80 | 118,90 | 117,08 | 118,43 | -0,36% | 1,53% | 5.754.400 |
| 10/01/2024 | 118,19 | 119,17 | 117,74 | 118,86 | +0,36% | 1,21% | 7.129.100 |
| 09/01/2024 | 117,51 | 119,94 | 117,21 | 118,43 | +0,89% | 2,32% | 8.822.300 |
| 08/01/2024 | 117,59 | 117,89 | 116,18 | 117,38 | +0,14% | 1,45% | 8.193.100 |
| 05/01/2024 | 117,10 | 117,45 | 116,64 | 117,22 | +0,18% | 0,69% | 6.861.500 |
| 04/01/2024 | 115,92 | 117,65 | 115,86 | 117,01 | +1,95% | 1,54% | 11.492.200 |
| 03/01/2024 | 114,27 | 115,90 | 114,16 | 114,77 | +1,35% | 1,52% | 10.721.900 |
| 02/01/2024 | 109,16 | 113,32 | 109,16 | 113,24 | +3,87% | 3,81% | 11.920.100 |
| 29/12/2023 | 108,99 | 109,24 | 108,79 | 109,02 | +0,23% | 0,41% | 5.889.200 |
| 28/12/2023 | 108,30 | 109,06 | 108,13 | 108,77 | +0,73% | 0,86% | 5.530.400 |
| 27/12/2023 | 107,31 | 108,07 | 107,01 | 107,98 | +0,33% | 0,99% | 5.387.000 |
| 26/12/2023 | 107,50 | 108,09 | 107,22 | 107,63 | -0,06% | 0,81% | 4.727.700 |
| 22/12/2023 | 107,15 | 108,06 | 106,84 | 107,70 | +1,23% | 1,14% | 6.028.700 |
| 21/12/2023 | 105,79 | 106,61 | 105,34 | 106,39 | +0,98% | 1,20% | 5.919.400 |
| 20/12/2023 | 107,14 | 107,14 | 105,24 | 105,36 | -1,06% | 1,77% | 8.441.600 |
| 19/12/2023 | 106,05 | 106,66 | 105,44 | 106,49 | +0,42% | 1,15% | 8.043.100 |
| 18/12/2023 | 106,16 | 107,21 | 105,63 | 106,04 | +0,88% | 1,49% | 12.805.600 |
| 15/12/2023 | 104,89 | 106,27 | 104,26 | 105,11 | -0,73% | 1,92% | 26.393.300 |
| 14/12/2023 | 106,68 | 107,21 | 105,14 | 105,88 | -1,15% | 1,94% | 10.723.000 |
| 13/12/2023 | 104,16 | 107,11 | 103,97 | 107,11 | +2,64% | 3,01% | 10.995.000 |
| 12/12/2023 | 104,48 | 104,79 | 103,42 | 104,36 | -0,01% | 1,31% | 7.933.500 |
| 11/12/2023 | 104,85 | 105,47 | 103,57 | 104,37 | +0,60% | 1,81% | 7.429.700 |
| 08/12/2023 | 103,79 | 104,01 | 102,65 | 103,75 | -0,13% | 1,31% | 7.530.300 |
| 07/12/2023 | 105,59 | 105,60 | 103,73 | 103,88 | -1,66% | 1,77% | 9.602.200 |
| 06/12/2023 | 106,25 | 106,57 | 105,43 | 105,63 | -0,56% | 1,07% | 9.954.800 |
| 05/12/2023 | 104,92 | 106,40 | 104,18 | 106,23 | +1,11% | 2,12% | 10.789.100 |